Medipharm Labs Corp
TSX:LABS

Watchlist Manager
Medipharm Labs Corp Logo
Medipharm Labs Corp
TSX:LABS
Watchlist
Price: 0.065 CAD
Market Cap: 27.3m CAD

Medipharm Labs Corp
Total Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Medipharm Labs Corp
Total Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Medipharm Labs Corp
TSX:LABS
Total Liabilities
CA$8.7m
CAGR 3-Years
-7%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Total Liabilities
$27.4B
CAGR 3-Years
1%
CAGR 5-Years
-2%
CAGR 10-Years
-4%
Canopy Growth Corp
TSX:WEED
Total Liabilities
CA$333.8m
CAGR 3-Years
-42%
CAGR 5-Years
-27%
CAGR 10-Years
40%
Sundial Growers Inc
NASDAQ:SNDL
Total Liabilities
CA$218.8m
CAGR 3-Years
-17%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Total Liabilities
$95.9m
CAGR 3-Years
30%
CAGR 5-Years
-9%
CAGR 10-Years
50%
K
Knight Therapeutics Inc
TSX:GUD
Total Liabilities
CA$281.8m
CAGR 3-Years
16%
CAGR 5-Years
16%
CAGR 10-Years
61%
No Stocks Found

Medipharm Labs Corp
Glance View

Market Cap
27.3m CAD
Industry
Pharmaceuticals

MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company is headquartered in Barrie, Ontario and currently employs 190 full-time employees. The company went IPO on 2018-02-09. The firm produces purified, pharmaceutical-like cannabis extracts and related derivative products. The firm formulates, processes, packages and distributes cannabis extracts and cannabinoid-based products at its Canadian and Australian facilities for domestic and international markets. The Company, through its subsidiaries is engaged in the sale and distribution of cannabis oil, cannabis extracts, cannabis edibles, cannabis topicals, and derivatives to authorized classes of purchasers, as well as controlled human administration trials for sensory testing of cannabis extracts and derivative products. The company is also engaged in the manufacturing of extracts and tinctures of cannabis and cannabis resin for the purpose of a clinical trial or prescribed as medical cannabis products. The firm's wholly owned subsidiaries include MediPharm Labs Inc. and MediPharm Labs Australia Pty. Ltd.

LABS Intrinsic Value
0.114 CAD
Undervaluation 43%
Intrinsic Value
Price

See Also

What is Medipharm Labs Corp's Total Liabilities?
Total Liabilities
8.7m CAD

Based on the financial report for Sep 30, 2025, Medipharm Labs Corp's Total Liabilities amounts to 8.7m CAD.

What is Medipharm Labs Corp's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
-28%

Over the last year, the Total Liabilities growth was -19%. The average annual Total Liabilities growth rates for Medipharm Labs Corp have been -7% over the past three years , -28% over the past five years .

Back to Top